{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:22:13Z","timestamp":1708474933110},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"DOI":"10.7759\/cureus.54555","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T17:33:55Z","timestamp":1708450435000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Acute Upper Gastrointestinal Bleed Due to Diffuse B-cell Lymphoma of the Duodenum in a Renal Transplant Patient: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Michael","family":"Ladna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E","family":"Forsmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network","volume":"11","author":"Sprangers B","year":"2018","unstructured":"Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Clin Kidney J. 2018, 11:315-29. 10.1093\/ckj\/sfx122","journal-title":"Clin Kidney J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.206456","article-title":"Postrenal transplant malignancy: incidence, risk factors, and prognosis","volume":"28","author":"Elserwy NA","year":"2017","unstructured":"Elserwy NA, Lotfy EE, Fouda MA, et al.. Postrenal transplant malignancy: incidence, risk factors, and prognosis. Saudi J Kidney Dis Transpl. 2017, 28:579-88. 10.4103\/1319-2442.206456","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9327868","article-title":"Clinicopathological features, treatment strategy, and prognosis of primary non-Hodgkin\u2019s lymphoma of the duodenum: a SEER database analysis","volume":"2020","author":"Zheng G","year":"2020","unstructured":"Zheng G, Wang Y, Zhao Y, Zheng Z. Clinicopathological features, treatment strategy, and prognosis of primary non-Hodgkin\u2019s lymphoma of the duodenum: a SEER database analysis. Can J Gastroenterol Hepatol. 2020, 2020:9327868. 10.1155\/2020\/9327868","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt188","article-title":"Bowel perforation in intestinal lymphoma: incidence and clinical features","volume":"24","author":"Vaidya R","year":"2013","unstructured":"Vaidya R, Habermann TM, Donohue JH, et al.. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013, 24:2439-43. 10.1093\/annonc\/mdt188","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire P","year":"2011","unstructured":"Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011, 17:697-707. 10.3748\/wjg.v17.i6.697","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000350051","article-title":"Gastrointestinal lymphoma: recent advances in diagnosis and treatment","volume":"87","author":"Nakamura S","year":"2013","unstructured":"Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013, 87:182-8. 10.1159\/000350051","journal-title":"Digestion"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2012.024","article-title":"Gastrointestinal lymphomas: morphology, immunophenotype and molecular features","volume":"3","author":"Bautista-Quach MA","year":"2012","unstructured":"Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012, 3:209-25. 10.3978\/j.issn.2078-6891.2012.024","journal-title":"J Gastrointest Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02687-x","article-title":"Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients","volume":"110","author":"Maeshima AM","year":"2019","unstructured":"Maeshima AM, Taniguchi H, Ito Y, et al.. Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients. Int J Hematol. 2019, 110:340-6. 10.1007\/s12185-019-02687-x","journal-title":"Int J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i12.1852","article-title":"Review of lymphoma in the duodenum: an update of diagnosis and management","volume":"29","author":"Iwamuro M","year":"2023","unstructured":"Iwamuro M, Tanaka T, Okada H. Review of lymphoma in the duodenum: an update of diagnosis and management. World J Gastroenterol. 2023, 29:1852-62. 10.3748\/wjg.v29.i12.1852","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i36.12993","article-title":"Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up","volume":"20","author":"Vetro C","year":"2014","unstructured":"Vetro C, Romano A, Amico I, et al.. Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up. World J Gastroenterol. 2014, 20:12993-3005. 10.3748\/wjg.v20.i36.12993","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0423","article-title":"Post renal-transplant malignancy surveillance","volume":"20","author":"Manickavasagar R","year":"2020","unstructured":"Manickavasagar R, Thuraisingham R. Post renal-transplant malignancy surveillance. Clin Med (Lond). 2020, 20:142-5. 10.7861\/clinmed.2019-0423","journal-title":"Clin Med (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan SC","year":"2011","unstructured":"Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011, 86:206-9. 10.1002\/ajh.21911","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz G","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993, 342:1514-6. 10.1016\/S0140-6736(05)80084-4","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22636","article-title":"Risk factors for malignancy in Japanese renal transplant recipients","volume":"109","author":"Imao T","year":"2007","unstructured":"Imao T, Ichimaru N, Takahara S, et al.. Risk factors for malignancy in Japanese renal transplant recipients. Cancer. 2007, 109:2109-15. 10.1002\/cncr.22636","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i7.1224","article-title":"Post-transplant lymphoproliferative disorder after liver transplantation: incidence, long-term survival and impact of serum tacrolimus level","volume":"23","author":"Eshraghian A","year":"2017","unstructured":"Eshraghian A, Imanieh MH, Dehghani SM, et al.. Post-transplant lymphoproliferative disorder after liver transplantation: incidence, long-term survival and impact of serum tacrolimus level. World J Gastroenterol. 2017, 23:1224-32. 10.3748\/wjg.v23.i7.1224","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio MS","year":"2012","unstructured":"Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Nephrol Dial Transplant. 2012, 27:2971-9. 10.1093\/ndt\/gfr769","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S326632","article-title":"Diffuse large B-cell lymphoma (DLBCL): early patient management and emerging treatment options","volume":"15","author":"Vodicka P","year":"2022","unstructured":"Vodicka P, Klener P, Trneny M. Diffuse large B-cell lymphoma (DLBCL): early patient management and emerging treatment options. Onco Targets Ther. 2022, 15:1481-501. 10.2147\/OTT.S326632","journal-title":"Onco Targets Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017734","article-title":"Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial","volume":"141","author":"Song Y","year":"2023","unstructured":"Song Y, Tilly H, Rai S, et al.. Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial. Blood. 2023, 141:1971-81. 10.1182\/blood.2022017734","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000648","article-title":"Management and outcomes of diffuse large B-cell lymphoma post-transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian Lymphoma Alliance","volume":"5","author":"Boyle S","year":"2021","unstructured":"Boyle S, Tobin JW, Perram J, et al.. Management and outcomes of diffuse large B-cell lymphoma post-transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian Lymphoma Alliance. Hemasphere. 2021, 5:e648. 10.1097\/HS9.0000000000000648","journal-title":"Hemasphere"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/214524-recurrent-acute-upper-gastrointestinal-bleed-due-to-diffuse-b-cell-lymphoma-of-the-duodenum-in-a-renal-transplant-patient-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T17:34:02Z","timestamp":1708450442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/214524-recurrent-acute-upper-gastrointestinal-bleed-due-to-diffuse-b-cell-lymphoma-of-the-duodenum-in-a-renal-transplant-patient-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.54555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}